Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
PaperCitations, authors & open-access status
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 237 citations, 2016 year and bronze oa status.
237
Citations
2016
Year
bronze
OA Status